Embecta Stock (NASDAQ:EMBC)
Previous Close
$18.98
52W Range
$9.93 - $21.48
50D Avg
$18.87
200D Avg
$14.89
Market Cap
$1.07B
Avg Vol (3M)
$418.36K
Beta
0.94
Div Yield
$0.60 (3.26%)
EMBC Company Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
EMBC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| BAX | Baxter International Inc. |
| RMD | ResMed Inc. |
| ICUI | ICU Medical, Inc. |
| NVST | Envista Holdings Corp |
| MMSI | Merit Medical Systems, Inc. |
| AKYA | Akoya Biosciences, Inc. |
| COO | The Cooper Companies, Inc. |
| ATRC | AtriCure, Inc. |
| TFX | Teleflex Incorporated |
| WST | West Pharmaceutical Services, Inc. |
| HAE | Haemonetics Corporation |
| ATR | AptarGroup, Inc. |
| ANGO | AngioDynamics, Inc. |
| ALC | Alcon Inc. |